Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SOX Chemotherapy”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Large-scale testing (Phase 3)UnknownNCT02817425
What this trial is testing

A Efficacy and Tolerability Study of TEGAFOX Sequential S-1 in the Treatment of Adjuvant Chemotherapy for Gastric Cancer

Who this might be right for
Gastric Cancer
LanZhou University 300
Large-scale testing (Phase 3)UnknownNCT02338518
What this trial is testing

Comparison of SEEOX and SOX Regimens in Stage ⅢB/ⅢC Gastric Cancer Patients

Who this might be right for
Stomach NeoplasmsGastric Cancer
Jinling Hospital, China 297
Large-scale testing (Phase 3)Not Yet RecruitingNCT04384601
What this trial is testing

Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer

Who this might be right for
Gastric CancerNeoadjuvant Chemotherapy
Ruijin Hospital 246
Not applicableStudy completedNCT01344304
What this trial is testing

Study of Aprepitant / Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting (CINV) in Colorectal Cancer Patients - SENRI Trial

Who this might be right for
Colorectal Cancer
Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group 413
Testing effectiveness (Phase 2)Looking for participantsNCT05170503
What this trial is testing

Neoadjuvant Immunochemotherapy in Locally Advanced Esophagogastric Junction Adenocarcinoma

Who this might be right for
Esophagogastric Junction Adenocarcinoma
Sun Yat-sen University 37
Testing effectiveness (Phase 2)UnknownNCT04410887
What this trial is testing

Neoadjuvant Chemotherapy With PISOXO for Locally-invaded-gastric Cancer (LIGC)

Who this might be right for
Stomach CancerGastric Cancer
Ruijin Hospital 30
Testing effectiveness (Phase 2)UnknownNCT01542294
What this trial is testing

SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer

Who this might be right for
Gastric Cancer
Chinese Academy of Medical Sciences 71
Testing effectiveness (Phase 2)Looking for participantsNCT06461910
What this trial is testing

Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric CancerEsophagogastric Junction Adenocarcinoma
Zekuan Xu 30
Testing effectiveness (Phase 2)UnknownNCT01811277
What this trial is testing

SOX Sequential S-1 in Advanced Biliary Tract Carcinoma（BTC）and Pancreatic Cancer

Who this might be right for
Biliary Tract CancerPeriampullary AdenocarcinomaPancreatic Cancer
Peking University 40
Testing effectiveness (Phase 2)UnknownNCT02280070
What this trial is testing

RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).

Who this might be right for
Rectal Cancer
Clinical Research Support Center Kyush 110
Testing effectiveness (Phase 2)UnknownNCT03279614
What this trial is testing

Study to Evaluate the Efficiency of SOX as Seconde-line Chemotherapy in Neuroendocrine Carcinoma

Who this might be right for
Neuroendocrine Carcinoma
Peking University 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07727993
What this trial is testing

Neoadjuvant Propranolol Plus SOX and Toripalimab for Locally Advanced Gastric/GEJ Adenocarcinoma

Who this might be right for
Gastric or Gastroesophageal Junction AdenocarcinomaPropranololSOX Chemotherapy+1 more
Ting Liu 49
Testing effectiveness (Phase 2)UnknownNCT02024217
What this trial is testing

Neoadjuvant Chemotherapy Plus Chemoradiation in Patients With Potentially Resectable Gastric Carcinoma

Who this might be right for
Gastric Cancer
Fudan University 40
Testing effectiveness (Phase 2)Looking for participantsNCT04908566
What this trial is testing

Immune Checkpoint Inhibitor PD-1 Antibody Combined With Chemotherapy in the Perioperative Treatment of Locally Advanced Resectable Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Locally Advanced Gastric Adenocarcinoma
Tianjin Medical University Cancer Institute and Hospital 124
Testing effectiveness (Phase 2)Looking for participantsNCT06196697
What this trial is testing

AK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for Advanced G/GEJ Cancer

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Harbin Medical University 50
Large-scale testing (Phase 3)UnknownNCT03448549
What this trial is testing

SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients

Who this might be right for
Colorectal Cancer Stage IIIAdjuvant Chemotherapy
Peking University Cancer Hospital & Institute 1,191
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06213519
What this trial is testing

HIPEC Combined With SOX and Sintilimab in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis

Who this might be right for
Peritoneal MetastasesGastric Cancer
Sichuan University 69
Not applicableLooking for participantsNCT06597227
What this trial is testing

Proximal Gastrectomy vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy

Who this might be right for
Locally Advanced Gastric Cancer
Guihua Wang 404
Testing effectiveness (Phase 2)UnknownNCT03702491
What this trial is testing

Apapitatin Combined With SOX for Palliative Adjuvant Chemotherapy in Patients With Advanced Gallbladder Carcinoma

Who this might be right for
Gallbladder Carcinoma
Eastern Hepatobiliary Surgery Hospital 138
Testing effectiveness (Phase 2)UnknownNCT04782791
What this trial is testing

Nivolumab, S-1 Combined With Oxaliplatin Versus Nivolumab as Neoadjuvant Therapy in Advanced Gastric Cancer

Who this might be right for
Gastric CancerChemotherapy Effect
Chinese PLA General Hospital 30
Next Page